Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

YSBPW YS Biopharma Company Ltd

0,094999

0,00 (0,00%)

Nach Börsenschluss

Zuletzt aktualisiert: 01:00:00

Verzögert um 15 Minuten

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

YS Biopharma (NASDAQ:YSBPW)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more YS Biopharma Charts.

YS Biopharma (NASDAQ:YSBPW)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more YS Biopharma Charts.

News YS Biopharma Company Ltd

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
Dienstag 10 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 10 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 4 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 15 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Donnerstag 15 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form NT 20-F - Notification of inability to timely file Form 20-F
Mittwoch 31 Juli 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 5 Juli 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 18 Juni 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 10 Juni 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 24 Mai 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 21 Mai 2024 (5 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Montag 20 Mai 2024 (6 Monate vor) • Edgar (US Regulatory)

Weitere YS Biopharma Company Ltd News-Artikel

FTAC Emerald Acquisition

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen